These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 15154679
1. The inhibitory role of methylation on the binding characteristics of dopamine receptors and transporter. Lee ES, Chen H, Shepherd KR, Lamango NS, Soliman KF, Charlton CG. Neurosci Res; 2004 Mar; 48(3):335-44. PubMed ID: 15154679 [Abstract] [Full Text] [Related]
2. Acquisition of an appetitive behavior prevents development of stress-induced neurochemical modifications in rat nucleus accumbens. Nanni G, Scheggi S, Leggio B, Grappi S, Masi F, Rauggi R, De Montis MG. J Neurosci Res; 2003 Aug 15; 73(4):573-80. PubMed ID: 12898542 [Abstract] [Full Text] [Related]
3. Lysophosphatidylcholine decreases locomotor activities and dopamine turnover rate in rats. Lee ES, Soliman KF, Charlton CG. Neurotoxicology; 2005 Jan 15; 26(1):27-38. PubMed ID: 15527871 [Abstract] [Full Text] [Related]
4. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies. Kilbourn MR, Sherman PS, Kuszpit K. Synapse; 2002 Mar 01; 43(3):188-94. PubMed ID: 11793424 [Abstract] [Full Text] [Related]
5. Dopaminergic innervation of the human striatum in Parkinson's disease. Porritt M, Stanic D, Finkelstein D, Batchelor P, Lockhart S, Hughes A, Kalnins R, Howells D. Mov Disord; 2005 Jul 01; 20(7):810-8. PubMed ID: 15726582 [Abstract] [Full Text] [Related]
6. Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system. Bock N, Moll GH, Wicker M, Pilz J, Rüther E, Banaschewski T, Huether G, Rothenberger A. Pharmacopsychiatry; 2004 Jul 01; 37(4):163-7. PubMed ID: 15467972 [Abstract] [Full Text] [Related]
7. Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain. Kilbourn MR, Kemmerer ES, Desmond TJ, Sherman PS, Frey KA. Exp Neurol; 2004 Aug 01; 188(2):387-90. PubMed ID: 15246838 [Abstract] [Full Text] [Related]
8. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation. Kulkarni SS, Grundt P, Kopajtic T, Katz JL, Newman AH. J Med Chem; 2004 Jun 17; 47(13):3388-98. PubMed ID: 15189035 [Abstract] [Full Text] [Related]
9. Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice. Short JL, Ledent C, Borrelli E, Drago J, Lawrence AJ. Neuroscience; 2006 May 12; 139(2):661-70. PubMed ID: 16476524 [Abstract] [Full Text] [Related]
10. Enhanced dopamine uptake in the striatum following repeated restraint stress. Copeland BJ, Neff NH, Hadjiconstantinou M. Synapse; 2005 Sep 01; 57(3):167-74. PubMed ID: 15945060 [Abstract] [Full Text] [Related]
11. Analysis of four dopaminergic tracers kinetics using two different tissue input function methods. Sossi V, Holden JE, Chan G, Krzywinski M, Stoessl AJ, Ruth TJ. J Cereb Blood Flow Metab; 2000 Apr 01; 20(4):653-60. PubMed ID: 10779009 [Abstract] [Full Text] [Related]
12. Dopamine receptor and transporter levels are altered in the brain of Purkinje Cell Degeneration mutant mice. Delis F, Mitsacos A, Giompres P. Neuroscience; 2004 Apr 01; 125(1):255-68. PubMed ID: 15051164 [Abstract] [Full Text] [Related]
13. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. Biol Psychiatry; 2005 Feb 01; 57(3):229-38. PubMed ID: 15691523 [Abstract] [Full Text] [Related]
14. D2 autoreceptors are not involved in the down-regulation of the striatal dopamine transporter caused by alpha-methyl-p-tyrosine. Han S, Rowell PP, Carr LA. Res Commun Mol Pathol Pharmacol; 1999 Feb 01; 104(3):331-8. PubMed ID: 10741383 [Abstract] [Full Text] [Related]
15. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake. Storch A, Hwang YI, Gearhart DA, Beach JW, Neafsey EJ, Collins MA, Schwarz J. J Neurochem; 2004 May 01; 89(3):685-94. PubMed ID: 15086525 [Abstract] [Full Text] [Related]
16. Effects of long-term biogenic amine transporter blockade on receptor/G-protein coupling in rat brain. O'Connor KA, Gregg TC, Davies HM, Childers SR. Neuropharmacology; 2005 Jan 01; 48(1):62-71. PubMed ID: 15617728 [Abstract] [Full Text] [Related]
17. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents. Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M. J Med Chem; 2005 Apr 07; 48(7):2559-70. PubMed ID: 15801845 [Abstract] [Full Text] [Related]
18. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes. Odagaki Y, Toyoshima R. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1304-12. PubMed ID: 16824659 [Abstract] [Full Text] [Related]
19. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm. Bailey A, Metaxas A, Yoo JH, McGee T, Kitchen I. Eur J Neurosci; 2008 Aug 30; 28(4):759-70. PubMed ID: 18671743 [Abstract] [Full Text] [Related]
20. Neurochemical alterations produced by daily nicotine exposure in periadolescent vs. adult male rats. Collins SL, Wade D, Ledon J, Izenwasser S. Eur J Pharmacol; 2004 Oct 11; 502(1-2):75-85. PubMed ID: 15464092 [Abstract] [Full Text] [Related] Page: [Next] [New Search]